首页> 外国专利> APOPTOTIC Apo2L/TRAIL SENSITIVITY BY TESTING GalNac-T14 EXPRESSION IN CELLS/TISSUES

APOPTOTIC Apo2L/TRAIL SENSITIVITY BY TESTING GalNac-T14 EXPRESSION IN CELLS/TISSUES

机译:通过测试细胞/组织中GalNac-T14的表达对细胞凋亡Apo2L / TRAIL的敏感性

摘要

FIELD: medicine.;SUBSTANCE: inventions concern methods and analyses for studying expression of one or more biomarkers in a mammal's tissue or cell sample; study kits and products are presented also. Identifying expression of GalNac-T14 molecules predicts sensitivity or specifies that the tissue or cell sample is supposed to be sensitive to apoptosis inducing agents, such as Apo2L/TRAIL.;EFFECT: information obtained by the analysis aiming at identifying GalNac-T14 expression in the tissue or the cell sample in a mammal can provide an attending physician with the information which can be used for prescribing an optimum treatment regimen for the patients suffering such diseases as pancreatic cancer, lymphoma, non-small cell carcinoma of lung, colon cancer, rectal cancer, melanoma or chondrosarcoma.;22 cl, 50 dwg, 6 tbl
机译:领域:发明涉及研究哺乳动物组织或细胞样品中一种或多种生物标志物表达的方法和分析;还介绍了学习套件和产品。鉴定GalNac-T14分子的表达可预测敏感性,或指定组织或细胞样品对凋亡诱导剂(例如Apo2L / TRAIL)敏感。效果:通过分析获得的信息旨在鉴定GalNac-T14分子中的GalNac-T14表达。哺乳动物的组织或细胞样品可以为主治医生提供信息,这些信息可用于为患有诸如胰腺癌,淋巴瘤,非小细胞肺癌,结肠癌,直肠癌等疾病的患者开出最佳治疗方案癌症,黑色素瘤或软骨肉瘤; 22 cl,50 dwg,6 tbl

著录项

  • 公开/公告号RU2416097C2

    专利类型

  • 公开/公告日2011-04-10

    原文格式PDF

  • 申请/专利权人 DZHENENTEK INK.;

    申请/专利号RU20080110089

  • 申请日2006-08-15

  • 分类号G01N33/68;

  • 国家 RU

  • 入库时间 2022-08-21 17:48:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号